Get helpful answers to top legal questions, instantly.
Stribild is a once-a-day tablet created by Gilead Sciences to treat HIV. The FDA approved it in 2012. However, Stribild contains tenofovir disoproxil fumarate (TDF), which may lead to serious kidney and bone injuries. Some lawsuits show Stribild is even more toxic than other TDF drugs.
Why Take Legal Action?
By filing a dangerous drug lawsuit, you can pursue financial compensation and justice from the companies that caused you or a loved one harm.
Results Secured
Stribild is an HIV drug containing the antiretroviral medicines elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (TDF). Created by Gilead Sciences, it was approved by the FDA on August 27th, 2012 as an all-in-one HIV treatment pill.
Despite its effectiveness, Stribild comes with a high price tag and many health risks, including serious kidney and bone problems. Some Stribild users are now filing lawsuits to compensate them for injuries Gilead allegedly could have avoided by using a safer alternative to a TDF-containing medication.
Stribild is typically prescribed to people who are at least 12 years old and have not received anti-HIV medicines before.
Anyone considering a new medication or stopping an existing medication should consult their doctor for medical advice.
Stribild’s most common side effects are nausea and diarrhea. However, Stribild has more serious side effects, including kidney and bone issues, lactic acidosis, and worsening Hepatitis B in patients who stop taking Stribild.
Many victims of Stribild’s more severe side effects have argued that Gilead not only withheld safer versions of their HIV drugs to maximize profit — they also downplayed the seriousness of these drugs’ potential side effects in the United States.
Stribild was approved for sale by the FDA on August 27th, 2012.
According to recent lawsuits filed against Gilead Sciences, Gilead had more than 10 years of evidence that TDF damaged patients’ kidneys and bones by the time it applied for FDA approval of Stribild.
Stribild has a very high price tag. Depending on pharmacy and insurance, costs can range from $3,000 to $3,700 per month.
The lawsuits also claim Gilead discovered a safer TDF alternative, tenofovir alafenamide fumarate (TAF) before it even gained FDA approval to market TDF under the brand name Viread in 2001.
Gilead’s once-a-day HIV drug, Stribild, can be a convenient and effective way to manage HIV. However, it may cause serious injuries to the kidneys and bones.
Because of this, Stribild has been named in several lawsuits in which plaintiffs accused Gilead Sciences of causing unnecessary harm to HIV drug users by withholding its TDF alternative, TAF.
Although nothing can reverse the harm and pain caused by irresponsible companies, taking legal action may help those affected receive financial compensation for their suffering and medical treatments.
Pursuing a lawsuit can be intimidating and overwhelming, but if you have been harmed by taking Stribild or another TDF drug, help is available to you.
Written by: LawFirm.com
LawFirm.com makes it easier to take legal action. We have information, lawsuit guides, and breaking news about drugs, products, and other issues that could affect you.
If you or someone you love has suffered an injury as a result of someone else’s negligence, please complete our form for a free case review. You may be eligible for compensation.
Find out if you qualify now for free. Call (888) 726-9160